Nuzenio

Novartis

Novartis news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 18 latest news signals 13 publisher sources 100/100 entity strength

Latest news

Novartis Appoints Dima Sweiss as Country President – Levant - hrtoday.inhrtoday.in · Sat, 08 Aug 2026 17:49:48 GMTFDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease - NovartisNovartis · Sat, 08 Aug 2026 12:24:46 GMTDr Reddy's Terminates Novartis India Agreement After Ownership Change - NDTV ProfitNDTV Profit · Sat, 08 Aug 2026 05:35:44 GMTPatrick Soon-Shiong: Great to See That Novartis Drug With Lu177 Received Expanded Approval - oncodaily.comoncodaily.com · Thu, 06 Aug 2026 19:46:20 GMTNovartis marks 30 years of breakthroughs, building on 250 years of discovery to reimagine what medicine can do next - NovartisNovartis · Thu, 06 Aug 2026 15:35:50 GMTNovartis Enrolled First Participant in Phase 3 PRESERVE Clinical Trial for Experimental PSP-RS Treatment - AFTD - The Association for Frontotemporal DegenerationAFTD - The Association for Frontotemporal Degeneration · Wed, 05 Aug 2026 13:00:45 GMTResearch Analysts Offer Predictions for Novartis Q3 Earnings - MarketBeatMarketBeat · Wed, 05 Aug 2026 11:07:36 GMTSegall Bryant & Hamill LLC Purchases Shares of 18,792 Novartis AG $NVS - MarketBeatMarketBeat · Wed, 05 Aug 2026 09:40:43 GMT

Timeline

Sat, 08 Aug 2026 17:49:48 GMTNovartis Appoints Dima Sweiss as Country President – Levant - hrtoday.in
Sat, 08 Aug 2026 12:24:46 GMTFDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease - Novartis
Sat, 08 Aug 2026 05:35:44 GMTDr Reddy's Terminates Novartis India Agreement After Ownership Change - NDTV Profit
Thu, 06 Aug 2026 19:46:20 GMTPatrick Soon-Shiong: Great to See That Novartis Drug With Lu177 Received Expanded Approval - oncodaily.com
Thu, 06 Aug 2026 15:35:50 GMTNovartis marks 30 years of breakthroughs, building on 250 years of discovery to reimagine what medicine can do next - Novartis
Wed, 05 Aug 2026 13:00:45 GMTNovartis Enrolled First Participant in Phase 3 PRESERVE Clinical Trial for Experimental PSP-RS Treatment - AFTD - The Association for Frontotemporal Degeneration

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Novartis.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

13 distinct publisher/source names are currently connected to this entity page.